First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This clinical trial is the first-in-human study of CU06-1004. The purpose of this phase 1
study is to assess the safety and tolerability of single and multiple ascending oral doses of
CU06-1004 in healthy adult subjects.